Physician profile
Douglas Appel
NPI 1609213537
$4,404.43
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $2,128 · 2021: $1,418 · 2022: $274 · 2023: $37.61 · 2024: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $2,339.00 | 2020-2021 | |
| Wright Medical Technology, INC. | $996.70 | 2019-2020 | |
| Stryker Corporation | $569.99 | 2019-2022 | |
| Organogenesis INC. | $116.92 | 2024 | |
| Orthofix Medical, INC. | $105.30 | 2019 | |
| Eclipse Technology Solutions INC. | $80.47 | 2022-2024 | |
| Integra Lifesciences Corporation | $39.48 | 2019 | |
| Zimmer Biomet Holdings, INC. | $31.97 | 2019-2023 | Subchondroplasty Knee Kit |
| Smith+Nephew, INC. | $30.93 | 2020-2022 | |
| Zimvie INC. | $29.10 | 2022-2023 | |
| Osteomed LLC | $27.84 | 2020 | |
| Treace Medical Concepts, INC. | $24.79 | 2024 | |
| Bioventus LLC | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Appel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.